Matches in Wikidata for { <http://www.wikidata.org/entity/Q97685053> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q97685053 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97685053 description "scientific article published on 24 July 2020" @default.
- Q97685053 description "wetenschappelijk artikel" @default.
- Q97685053 description "наукова стаття, опублікована 24 липня 2020" @default.
- Q97685053 name "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 name "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 type Item @default.
- Q97685053 label "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 label "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 prefLabel "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 prefLabel "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 P1433 Q97685053-1962C61D-7E5A-48C8-A342-868B10DAA390 @default.
- Q97685053 P1476 Q97685053-CA813A31-A0B1-4205-8731-EE1450EBE6B0 @default.
- Q97685053 P2093 Q97685053-26149C30-FFDC-44CF-9520-AB644C1D02B3 @default.
- Q97685053 P2093 Q97685053-77A682A4-CB3F-42AD-9CEC-9F9D33A50912 @default.
- Q97685053 P2093 Q97685053-7C5384AD-D56A-4455-A811-C229B79350A7 @default.
- Q97685053 P2093 Q97685053-8433C40F-998F-4C2D-A22A-70AA01E75187 @default.
- Q97685053 P2093 Q97685053-8A496940-4ACD-4DEE-BBC8-7AB7A584AC93 @default.
- Q97685053 P2093 Q97685053-9A4367E8-EA6F-45FB-BA30-C4E2F4BDE999 @default.
- Q97685053 P2093 Q97685053-9F8B112E-8ADF-4CBE-A686-46E8D821E61E @default.
- Q97685053 P2093 Q97685053-BF67C6DC-C7BE-4D37-A567-4CD0004AE40D @default.
- Q97685053 P31 Q97685053-128EBBF4-F688-48DF-8A6F-B30B70416D89 @default.
- Q97685053 P356 Q97685053-7279516D-58A0-4156-A59B-0AEC37256623 @default.
- Q97685053 P50 Q97685053-660A6894-67DB-4AC6-94FE-563C7A187F8D @default.
- Q97685053 P577 Q97685053-4484A775-8DF3-4862-9589-467369AA848C @default.
- Q97685053 P698 Q97685053-C73A1FBE-62DA-4239-B0F9-15A0332C2E00 @default.
- Q97685053 P921 Q97685053-B33D5450-E6BB-4241-B98F-3D6B869FC55F @default.
- Q97685053 P921 Q97685053-CC3D0022-DAB2-4AE6-B82C-1B3D296FB442 @default.
- Q97685053 P356 1759-7714.13588 @default.
- Q97685053 P698 32706170 @default.
- Q97685053 P1433 Q26842004 @default.
- Q97685053 P1476 "Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer" @default.
- Q97685053 P2093 "Izumi Sato" @default.
- Q97685053 P2093 "Kazuki Hirose" @default.
- Q97685053 P2093 "Nobutaka Kataoka" @default.
- Q97685053 P2093 "Nozomi Tani" @default.
- Q97685053 P2093 "Takumi Sugimoto" @default.
- Q97685053 P2093 "Yuri Ogura" @default.
- Q97685053 P2093 "Yusuke Kunimatsu" @default.
- Q97685053 P2093 "Yusuke Tachibana" @default.
- Q97685053 P31 Q13442814 @default.
- Q97685053 P356 "10.1111/1759-7714.13588" @default.
- Q97685053 P50 Q53062256 @default.
- Q97685053 P577 "2020-07-24T00:00:00Z" @default.
- Q97685053 P698 "32706170" @default.
- Q97685053 P921 Q415588 @default.
- Q97685053 P921 Q418817 @default.